
Blood clots and abnormal bleeding in a small number of vaccine recipients in European countries have cast doubt on its safety, although no causative link has been found between the patients’ conditions and the vaccine.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OY87Ac
via
IFTTT
0 comments:
Post a Comment